Page last updated: 2024-10-24

chlorambucil and Hematemesis

chlorambucil has been researched along with Hematemesis in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Hematemesis: Vomiting of blood that is either fresh bright red, or older coffee-ground in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
EDMONDS, LC1
CARRERA, GM1
Lebacq, E1

Other Studies

2 other studies available for chlorambucil and Hematemesis

ArticleYear
EXTRAGENITAL CHORIOCARCINOMA.
    The Journal of pediatrics, 1965, Volume: 67

    Topics: Autopsy; Brain Neoplasms; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Drug Therapy; Epistaxi

1965
[Gastric localizations of chronic lymphoid leukemia].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Apr-14, Volume: 45, Issue:18

    Topics: Adult; Chlorambucil; Duodenal Neoplasms; Duodenal Ulcer; Gastric Mucosa; Hematemesis; Humans; Hyperp

1969